Cargando…

Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

Detalles Bibliográficos
Autores principales:	Lin, ChangDong, Li, Yue, Zhang, YueBin, Liu, ZhaoYuan, Mu, Xia, Gu, Chenjian, Liu, Jing, Li, Yutang, Li, GuoHui, Chen, JianFeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190569/ https://www.ncbi.nlm.nih.gov/pubmed/34112764 http://dx.doi.org/10.1038/s41392-021-00643-y

Ejemplares similares

Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction
por: Lin, ChangDong, et al.
Publicado: (2021)

Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein–ACE2 interaction
por: Yuan, MengYa, et al.
Publicado: (2021)

Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction
por: Zheng, Yun-zhe, et al.
Publicado: (2023)

Distinct chemokines selectively induce HIV-1 gp120-integrin α4β7 binding via triggering conformer-specific activation of α4β7
por: Wang, Shu, et al.
Publicado: (2021)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2
por: Gu, Chenjian, et al.
Publicado: (2021)

Protocol for fever-range whole-body hyperthermia (WBH) in mice to study febrile effect on T-cell adhesion and migration
por: Lin, ChangDong, et al.
Publicado: (2021)

Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
por: Tsai, Ming-Shao, et al.
Publicado: (2022)

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
por: Luan, Junwen, et al.
Publicado: (2020)

GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
por: Tsai, Ming-Shao, et al.
Publicado: (2021)

Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
por: Zhu, Rong, et al.
Publicado: (2023)

Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay
por: Xiang, Yusen, et al.
Publicado: (2023)

Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
por: Zheng, Guanhao, et al.
Publicado: (2022)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
por: Li, Changzhi, et al.
Publicado: (2022)

Correction: Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang
por: Luo, Yi, et al.
Publicado: (2019)

Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD–ACE2 complexes in living cells by competitive binding
por: Miao, Lu, et al.
Publicado: (2022)

Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody
por: Duan, Xuejun, et al.
Publicado: (2022)

Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2
por: Wei, Shuangshi, et al.
Publicado: (2021)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses
por: Su, Siyuan, et al.
Publicado: (2021)

Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective
por: Duru, Chidi Edbert, et al.
Publicado: (2021)

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
por: Ejemel, Monir, et al.
Publicado: (2020)

Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2
por: Yan, Renhong, et al.
Publicado: (2021)

Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
por: Wang, Gan, et al.
Publicado: (2020)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Day, Christopher J., et al.
Publicado: (2021)

De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2
por: Huang, Xiaoqiang, et al.
Publicado: (2020)

The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations
por: Neufurth, Meik, et al.
Publicado: (2020)

Correction: Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition
por: Liu, Chun Xi, et al.
Publicado: (2022)

A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
por: Wang, Xiaoning, et al.
Publicado: (2021)

Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants
por: Sang, Peng, et al.
Publicado: (2022)

Correction: Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats
por: Dalpiaz, EP. L. M., et al.
Publicado: (2015)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor
por: Liu, Jinbiao, et al.
Publicado: (2021)

SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium
por: Zhou, Ye, et al.
Publicado: (2021)

TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
por: Haga, Shiori, et al.
Publicado: (2010)

Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface
por: Pirolli, Davide, et al.
Publicado: (2023)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
por: Pei, Gaofeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gt3s8n7tiej9qavsgv8sea792e